Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer-Reference-Cited by-同舟云学术

Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer

Published:2016-05 Issue:5 Volume:137 Page:1610-1613.e7
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Ganson Nancy J.,Povsic Thomas J.,Sullenger Bruce A.,Alexander John H.,Zelenkofske Steven L.,Sailstad Jeffrey M.,Rusconi Christopher P.,Hershfield Michael S.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference14 articles.

1. Aptamers: an emerging class of therapeutics;Nimjee;Annu Rev Med,2005

2. Modulation of the coagulation cascade using aptamers;Woodruff;Arterioscler Thromb Vasc Biol,2015

3. A phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial;Povsic;Eur Heart J,2013

4. Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients;Hershfield;Arthritis Res Ther,2014

5. An Overview of the clinical safety experience of first- and second-generation antisense oligonucleotides;Kwoh,2007

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions;Progress in Polymer Science;2024-09

2. Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies;ACS Nano;2024-08-09

3. Mitigating the Effects of Persistent Antipolymer Immune Reactions in Nanomedicine: Evaluating Materials-Based Approaches Using Molecular Imaging;ACS Nano;2024-07-22

4. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

5. A functional RNA-origami as direct thrombin inhibitor with fast-acting and specific single-molecule reversal agents in vivo model;Molecular Therapy;2024-07